Enhancing and suppressive effects of immunosuppressants cyclosporin A, FK506, and KM2210 on the colony formation of murine bone marrow cells

被引:6
|
作者
Zhu, X
Imamura, M
Hashino, S
Tanaka, J
Kobayashi, S
Tao, HR
Asaka, M
Kasai, M
Matsudaira, T
Asano, S
机构
[1] HOKKAIDO UNIV,SCH MED,DEPT INTERNAL MED 3,KITA KU,SAPPORO,HOKKAIDO 060,JAPAN
[2] UNIV TOKYO,INST MED SCI,TOKYO,JAPAN
[3] SAPPORO HOKUYU HOSP,SAPPORO,HOKKAIDO,JAPAN
关键词
immunosuppressants; cyclosporin A; FK506; KM2210; hematopoiesis;
D O I
10.1007/s002770050122
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Immunosuppressants cyclosporin A (CsA), FK506, and KM2210 modulated colony formations of murine hematopoietic progenitor cells. In a 4-h treatment with CsA, 10 mu g/ml increased the formation of colony-forming units of mixed lineages (CFU-Mix) but decreased the formation of highly proliferative potential colony-forming units (CFU-HPP); 1 mu g/ml of CsA increased the formations of CFU-HPP, CFU-Mix, and colony-forming units of granulocytes/macrophages (CFU-GM); 0.1 mu g of CsA increased the formation of CFU-Mix and burst-forming units of erythroid lineage (BFU-E). Lower doses of CsA appeared to induce an increase in various colony formations. FK506 increased CFU-HPP and CFU-Mix formations at lower doses. Another immunosuppressant, KM2210, CFU-HPP and CFU-GM formations but CFU-Mix and BFU-E formations. In a 24-h treatment, 10 mu g/ml and 1 mu g/ml of CsA inhibited all the colony formations, but 0.1 mu g/ml of CsA increased CFU-Mix, CFU-GM, and BFU-E formations. Similarly, 100 ng/ml and 10 ng/ml of FK506 decreased all the colony formations but 1 ng/ml of FK506 increased CFU-HPP and CFU-GM formations. KM2210 inhibited all the colony formations. These findings showed that lower doses of CsA and FK506 appeared to increase the colony formations, although higher doses of these drugs decreased the colony formations, similar to the findings in a 4-h treatment. On the other hand, KM2210 showed opposing effects on colony formation with 4-h and 24-h treatments.
引用
收藏
页码:301 / 306
页数:6
相关论文
共 44 条
  • [1] DIFFERENTIAL-EFFECTS OF THE IMMUNOSUPPRESSANTS CYCLOSPORINE-A, FK506 AND KM2210 ON CYTOKINE GENE-EXPRESSION
    HAN, CW
    IMAMURA, M
    HASHINO, S
    ZHU, X
    TANAKA, J
    IMAI, K
    MATSUDAIRA, T
    ASANO, S
    BONE MARROW TRANSPLANTATION, 1995, 15 (05) : 733 - 739
  • [2] Effects of immunosuppressants, FK506 and cyclosporin A, on the osteogenic differentiation of rat mesenchymal stem cells
    Byun, Yu-Kyung
    Kim, Kyoung-Hwa
    Kim, Su-Hwan
    Kim, Young-Sung
    Koo, Ki-Tae
    Kim, Tai-Il
    Seol, Yang-Jo
    Ku, Young
    Rhyu, In-Chul
    Lee, Yong-Moo
    JOURNAL OF PERIODONTAL AND IMPLANT SCIENCE, 2012, 42 (03): : 73 - 80
  • [3] Effects of FK506 and cyclosporin A on proliferation, histamine release and phenotype of murine mast cells
    Toyota, N
    Hashimoto, Y
    Matsuo, S
    Kitamura, Y
    Iizuka, H
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 1996, 288 (08) : 474 - 480
  • [4] Use of FK506 and bone marrow mesenchymal stem cells for rat hind limb allografts
    Song, Youxin
    Wang, Zhujun
    Wang, Zhixue
    Zhang, Hong
    Li, Xiaohui
    Chen, Bin
    NEURAL REGENERATION RESEARCH, 2012, 7 (34) : 2681 - 2688
  • [5] The efficiency of FK 506 in in vitro ebone formation by human bone marrow cells
    Okumura, N
    Yoshikawa, T
    Iida, J
    Ichijima, K
    Takakura, Y
    BIOCERAMICS 15, 2003, 240-2 : 659 - 661
  • [6] Results of a phase III study on prophylactic use of FK506 for acute GVHD compared with cyclosporin in allogeneic bone marrow transplantation.
    Hiraoka, A
    BLOOD, 1997, 90 (10) : 2500 - 2500
  • [7] Cationic amino acid transport systems are differentially inhibited by the immunosuppressants FK506 and cyclosporin A (CsA) in activated human peripheral blood mononuclear cells (PBMC)
    Chen, S
    Boyd, CAR
    JOURNAL OF PHYSIOLOGY-LONDON, 1996, 491P : P173 - P173
  • [8] Combination therapy with bone marrow stromal cells and FK506 enhanced amelioration of ischemic brain damage in rats
    Suda, Satoshi
    Shimazaki, Kuniko
    Ueda, Masayuki
    Inaba, Toshiki
    Kamiya, Nobuo
    Katsura, Ken-ichiro
    Katayama, Yasuo
    LIFE SCIENCES, 2011, 89 (1-2) : 50 - 56
  • [9] Stimulation of osteoblastic activity from bone marrow cells by in vitro application of FK506, a potent osteogenic agent.
    Dong, J
    Kojima, H
    Uemura, T
    Yoshikawa, T
    Tateishi, T
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S496 - S496
  • [10] ENHANCING AND SUPPRESSING EFFECTS OF RECOMBINANT MURINE MACROPHAGE INFLAMMATORY PROTEINS ON COLONY FORMATION INVITRO BY BONE-MARROW MYELOID PROGENITOR CELLS
    BROXMEYER, HE
    SHERRY, B
    LU, L
    COOPER, S
    OH, KO
    TEKAMPOLSON, P
    KWON, BS
    CERAMI, A
    BLOOD, 1990, 76 (06) : 1110 - 1116